发明授权
- 专利标题： Method to treat inflammation with humanized anti-IL-8-antibodies
- 专利标题（中）： 用人源化抗IL-8抗体治疗炎症的方法
-
申请号： US921100申请日： 1997-08-29
-
公开(公告)号： US6024956A公开(公告)日： 2000-02-15
- 发明人: Kouji Matsushima , Yoshihiro Matsumoto , Yoshiki Yamada , Koh Sato , Masayuki Tsuchiya , Tatsumi Yamazaki
- 申请人： Kouji Matsushima , Yoshihiro Matsumoto , Yoshiki Yamada , Koh Sato , Masayuki Tsuchiya , Tatsumi Yamazaki
- 申请人地址： JPX Tokyo
- 专利权人： Chugai Pharmaceutical Co., Ltd.
- 当前专利权人： Chugai Pharmaceutical Co., Ltd.
- 当前专利权人地址： JPX Tokyo
- 优先权： JPX6-161481 19940713
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; A61P29/00 ; A61P37/02 ; C07K16/24 ; C12N15/13 ; C12P21/08
摘要：
Monoclonal antibodies immunospecific for the neutrophil chemotactic factor, IL-8, have been humanized by reshaping the variable regions to conform more closely to human counterparts. These antibodies are useful in immunoassays to detect IL-8 and as ligands on immunoaffinity columns for purification of human IL-8. In addition, the humanized antibodies have an antiinflammatory effect in patients.